23 employees
PharmAbcine develops fully human therapeutic monoclonal antibodies for the treatment of cancer and inflammatory diseases.
2008
$6M
from 1 investors over 1 rounds
PharmAbcine Inc. raised $6M on September 16, 2009
Investors: OrbiMed Advisors